Macdonald, RL.; Kassell, NF.; Mayer, S.; Ruefenacht, D.; Schmiedek, P.; Weidauer, S.; Frey, A.; Roux, S.; Pasqualin, A.; Raabe, A. (2008). Clazosentan to overcome neuroslogical ischemia and infarction occurring after subarachnoid hermorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke, 39(11), pp. 3015-3021. Baltimore, Md.: Lippincott Williams & Wilkins 10.1161/STROKEAHA.108.519942
Full text not available from this repository. (Request a copy)Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) 04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurosurgery |
UniBE Contributor: |
Frey, Andrea, Raabe, Andreas |
ISSN: |
0039-2499 |
Publisher: |
Lippincott Williams & Wilkins |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 15:04 |
Last Modified: |
05 Dec 2022 14:19 |
Publisher DOI: |
10.1161/STROKEAHA.108.519942 |
Web of Science ID: |
000260427100018 |
URI: |
https://boris.unibe.ch/id/eprint/27841 (FactScience: 112598) |
Actions (login required)
 |
Edit item |